| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
26,220 |
20,836 |
$1.09M |
| 90460 |
Immunization administration through 18 years of age via any route, first or only component |
15,049 |
13,071 |
$552K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
5,827 |
5,152 |
$384K |
| 96110 |
Developmental screening, with scoring and documentation, per standardized instrument |
13,630 |
12,150 |
$317K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
5,364 |
4,505 |
$311K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
4,578 |
3,998 |
$298K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
4,211 |
3,709 |
$262K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
2,501 |
2,175 |
$180K |
| 92552 |
|
9,320 |
8,037 |
$140K |
| 99381 |
|
802 |
616 |
$46K |
| 87428 |
|
720 |
629 |
$44K |
| 96127 |
|
6,803 |
5,798 |
$42K |
| 99173 |
|
8,745 |
7,550 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
2,013 |
1,703 |
$35K |
| 96161 |
|
3,052 |
2,280 |
$29K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,075 |
942 |
$27K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
2,571 |
2,300 |
$24K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
489 |
457 |
$18K |
| 3008F |
|
11,360 |
9,938 |
$16K |
| G0447 |
Face-to-face behavioral counseling for obesity, 15 minutes |
1,032 |
768 |
$16K |
| 83655 |
|
1,641 |
1,476 |
$15K |
| 90686 |
|
6,787 |
5,937 |
$15K |
| 90651 |
|
1,818 |
1,526 |
$13K |
| 96160 |
|
1,398 |
1,208 |
$11K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
305 |
293 |
$10K |
| 90697 |
|
1,103 |
998 |
$10K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
77 |
75 |
$5K |
| 90670 |
|
3,521 |
3,133 |
$5K |
| 85018 |
|
2,607 |
2,294 |
$5K |
| 95115 |
|
554 |
202 |
$5K |
| 90619 |
|
290 |
216 |
$4K |
| 99383 |
|
57 |
52 |
$4K |
| 92558 |
|
484 |
427 |
$2K |
| 90716 |
|
1,749 |
1,495 |
$2K |
| 90734 |
|
520 |
430 |
$2K |
| 90681 |
|
1,617 |
1,464 |
$1K |
| 90698 |
|
1,114 |
1,027 |
$1K |
| 90620 |
|
116 |
92 |
$1K |
| 90677 |
|
415 |
403 |
$1K |
| 90707 |
|
1,714 |
1,471 |
$985.56 |
| 90633 |
|
2,223 |
1,932 |
$631.32 |
| 96381 |
|
57 |
53 |
$626.24 |
| 81002 |
|
265 |
236 |
$596.92 |
| 96380 |
|
43 |
29 |
$587.13 |
| 92588 |
|
36 |
29 |
$560.81 |
| 90381 |
|
70 |
65 |
$519.75 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
27 |
26 |
$391.58 |
| 90715 |
|
186 |
151 |
$292.78 |
| 95117 |
|
28 |
16 |
$281.28 |
| 90696 |
|
355 |
320 |
$259.21 |
| 36416 |
|
173 |
136 |
$193.26 |
| 86308 |
|
42 |
37 |
$175.05 |
| 90723 |
|
878 |
798 |
$170.72 |
| 99401 |
|
13 |
13 |
$104.25 |
| 90710 |
|
75 |
71 |
$79.22 |
| 90647 |
|
1,156 |
1,058 |
$67.48 |
| 90656 |
|
106 |
106 |
$26.40 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
44 |
39 |
$1.80 |
| 90685 |
|
423 |
366 |
$0.00 |
| 90700 |
|
193 |
178 |
$0.00 |
| 99499 |
|
598 |
538 |
$0.00 |
| 90380 |
|
44 |
30 |
$0.00 |
| G8482 |
Influenza immunization administered or previously received |
19 |
19 |
$0.00 |
| G8510 |
Screening for depression is documented as negative, a follow-up plan is not required |
255 |
234 |
$0.00 |
| 1036F |
|
77 |
74 |
$0.00 |